In conclusion, our study found that the MAFLD group had higher levels of adipsin and lower levels of adiponectin than the non-MAFLD group (regardless of whether each of BMI, MD, or T2DM was used as the diagnostic criterion alone for MAFLD). The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.